Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Sentiment | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|---|
| TGTX | TG THERAPEUTICS INC | $5.82B | 158,665,613 | 56.43% | 43.57% | Net Selling | Net Selling | ||
| CORT | CORCEPT THERAPEUTICS INC | $9.29B | 105,371,729 | 28.93% | 71.07% | Net Selling | Net Selling | ||
| CRMD | CORMEDIX INC | $769.13M | 67,824,659 | 50.35% | 10.08% | Net Selling | Net Selling | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $2.85B | 74,107,668 | 53.74% | 9.49% | Net Selling | Net Selling | ||
| HALO | HALOZYME THERAPEUTICS INC | $8.07B | 116,966,000 | 77.24% | 22.76% | Net Selling | Net Selling | ||
| KRYS | KRYSTAL BIOTECH INC | $5.31B | 28,942,981 | 78.75% | 21.25% | Net Selling | Net Selling | ||
| ARGX | ARGENX SE | $48.83B | 61,034,202 | 52.63% | 0.00% | ||||
| INVA | INNOVIVA INC | $1.10B | 63,021,014 | 59.69% | 40.31% | Net Selling | Net Selling | ||
| VCEL | VERICEL CORP | $1.64B | 50,460,205 | 91.49% | 8.51% | Net Selling | Net Selling | ||
| RPRX | ROYALTY PHARMA PLC | $21.04B | 583,174,298 | 58.59% | 17.24% | Net Selling | Net Selling | ||
| AUPH | AURINIA PHARMACEUTICALS INC | $1.49B | 131,629,546 | 44.23% | 12.63% | Net Buying | Net Buying | ||
| INCY | INCYTE CORP | $16.96B | 195,276,145 | 77.48% | 22.52% | Net Selling | Net Selling | ||
| EXEL | EXELIXIS INC | $10.79B | 269,202,521 | 94.68% | 5.32% | Net Selling | |||
| GYRE | GYRE THERAPEUTICS INC | $713.68M | 96,313,157 | 2.05% | 97.95% | Net Buying | |||
| ADMA | ADMA BIOLOGICS INC | $3.50B | 238,630,719 | 79.04% | 20.96% | Net Selling | Net Selling | ||
| MDXG | MIMEDX GROUP INC | $1.07B | 147,959,416 | 46.35% | 53.65% | Net Buying | |||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $1.57B | 57,532,601 | 77.54% | 22.46% | Net Selling | Net Selling | ||
| ATRA | ATARA BIOTHERAPEUTICS INC | $101.20M | 7,023,032 | 13.52% | 86.48% | Net Buying | Net Buying | ||
| TECH | BIO-TECHNE CORP | $9.79B | 155,549,587 | 97.62% | 2.38% | Net Buying | Net Buying | ||
| VCYT | VERACYTE INC | $2.82B | 78,314,611 | 66.66% | 33.34% | Net Selling | Net Selling | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $10.64B | 192,014,601 | 96.00% | 1.74% | Net Selling | Net Selling | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $103.40B | 256,390,651 | 93.79% | 1.51% | Net Selling | Net Buying | ||
| GMAB | GENMAB A | $21.53B | 64,154,254 | 99.31% | 0.00% | ||||
| CPRX | CATALYST PHARMACEUTICALS INC | $2.55B | 122,391,010 | 82.76% | 15.97% | Net Buying | Net Buying | ||
| NVO | NOVO NORDISK A S | $266.25B | 4,465,000,000 | 6.90% | 0.00% | ||||
| MNKD | MANNKIND CORP | $1.77B | 306,828,335 | 35.18% | 64.82% | Net Selling | Net Selling |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.